Skip to main content

Table 1 Patient characteristics

From: Plasma glutamine concentration after intensive care unit discharge: an observational study

  Gender (male) Age (years) SAPS III LOS (days) SOFA discharge Dialysis
Study A (n = 63) 39 (62%) 64 (56,71) 68 (62,80) 9 (7,14) 4 (2,8) 13 (21%)
Study A (n = 49) 31 (63%) 63 (55,72) 68 (60,80) 9 (6,13) 4 (2,7) 10 (20%)
  Survivors (n = 40) 26 (65%) 63 (56,71) 65 (62,74) 9 (6,13) 3 (2,5) 3 (8%)
  Nonsurvivors (n = 23) 13 (56%) 65 (61,71) 71 (64,89) 8 (7,14) 7 (4,9) 10 (43%)
  P value 0.59 0.62 0.042 0.81 0.00085 0.0012
Study B (n = 100) 58 (58%) 65 (56,72) 68 (61,77) 9 (6,14) 4 (2,6) 16 (16%)
Study B (n = 92) 55 (60%) 65 (56,72) 68 (62,78) 9 (6,13) 4 (2,7) 16 (17%)
  Survivors (n = 54) 32 (60%) 65 (56,72) 65 (58,70) 8 (6,11) 3 (2,5) 6 (11%)
  Nonsurvivors (n = 38) 23 (60%) 65 (60,72) 74 (66,88) 10 (6,16) 6 (2,8) 10 (26%)
  P value 1.00 0.74 0.0013 0.15 0.043 0.09
  1. All subjects included in Study A (n = 63) and subjects with post-ICU samples (n = 49), and all subjects included in Study B (n = 100) and subjects with post-ICU samples (n = 92). Comparison of survivors and nonsurvivors was done in each group using Mann-Whitney or Fischer’s exact tests. SAPS III, simplified acute physiology score III; LOS, length of stay; SOFA, sequential organ failure assessment.